Search Results - "Moirogiorgou, E."

Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting by Fountzilas, E., Koliou, G.-A., Rapti, V., Nikolakopoulos, A., Christopoulou, A., Moirogiorgou, E., Binas, I., Aravantinos, G., Kostadima, L., Nikolaidi, A., Karteri, S., Zagouri, F., Saridaki, Z., Molfeta, A., Oikonomopoulou, P., Res, E., Tryfonopoulos, D., Koumakis, G., Fountzilas, G., Razis, E.

Get full text

334PClinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting by Fountzilas, E, Koliou, G -A, Rapti, V, Nikolakopoulos, A, Christopoulou, A, Moirogiorgou, E, Binas, I, Aravantinos, G, Kostadima, L, Nikolaidi, A, Karteri, S, Zagouri, F, Saridaki, Z, Molfeta, A, Oikonomopoulou, P, Res, E, Tryfonopoulos, D, Koumakis, G, Fountzilas, G, Razis, E

“…Abstract Background Clinical trials evaluating treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in combination with aromatase inhibitors (AI) or…”
Get full text

334P - Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting by Fountzilas, E., Koliou, G.-A., Rapti, V., Nikolakopoulos, A., Christopoulou, A., Moirogiorgou, E., Binas, I., Aravantinos, G., Kostadima, L., Nikolaidi, A., Karteri, S., Zagouri, F., Saridaki, Z., Molfeta, A., Oikonomopoulou, P., Res, E., Tryfonopoulos, D., Koumakis, G., Fountzilas, G., Razis, E.

“…Clinical trials evaluating treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in combination with aromatase inhibitors (AI) or fulvestrant have…”
Get full text